select count(*) as counts from cancer where `biomolecule` LIKE '%DNA%' This page shows data for DNA biomolecule.
Browse Biomarkers Based on Biomolecules
This page shows data for DNA biomolecule.
Total Entries Retrieved: 19
| ID | Biomarker | Biomolecule | Subjects | Regulation | Type | Experiment | Level of Significance | Source | PMID |
|---|---|---|---|---|---|---|---|---|---|
| 484 | PSA+MMP-2+ AMACR + Methylation Status of (GSTP1 or RASSF1A) | Protein + DNA | Humans | Upregulated and Hypermethylated in PCa | Diagnostic | Prostate Cancer Vs No Tumor | p=0.036 | Urine and Serum | 20632177 |
| 500 | Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP)[Fixed | DNA (Gene) | Humans | Differentially Expressed | Prognostic | Biochemical recurrence (within 1 year ) Vs No recurrence (24 months) | NA | Tissue | 20028763 |
| 501 | Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) [Floating] | DNA (Gene) | Humans | Differentially Expressed | Prognostic | Biochemical recurrence (within 1 year ) Vs No recurrence (24 months) | NA | Tissue | 20028763 |
| 502 | Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) [Integrated] | DNA (Gene) | Humans | Differentially Expressed | Prognostic | Biochemical recurrence (within 1 year ) Vs No recurrence (24 months) | NA | Tissue | 20028763 |
| 932 | Modification Status of RNF219 | cirDNA | Humans | Highly modified in PCa Patients (Control: 55% | Diagnostic | PCA VS no history of prostate disease | p=3 *10^-41 | Plasma | 22619380 |
| 933 | Modification Status of RNF220 | cirDNA | Humans | Highly modified in PCa Patients (Control: 55% | Diagnostic | PCA Vs BPH | p = 1 *10^-4 | Plasma | 22619380 |
| 1725 | miR-24+miR-30c+ Methylation Status of CRIP3 | miRNA + DNA (Gene) | Humans | Increased in shorter BCR-free survival | Prognostic | Reclassification (Progression Vs No Progression) | Univariate: p=0.008; Multivariate: p=0.017 | Urine | 30777394 |
| 1894 | ASAP1 | DNA (Copy Number variations) | Humans | NA | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1895 | HDAC9 | DNA (Copy Number variations) | Humans | NA | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1896 | CHD1 | DNA (Copy Number variations) | Humans | NA | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1897 | RB1 | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1898 | PTEN | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1899 | MYC | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | Gleason Grade 4 in Gleason Score 7 | p<0.01 | Tissue | 30611450 |
| 1900 | ASAP1 | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |
| 1901 | HDAC9 | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |
| 1902 | CHD1 | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |
| 1903 | RB1 | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |
| 1904 | PTEN | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |
| 1905 | MYC | DNA (Copy Number variations) | Humans | Upregulated in Agressive PCa | Prognostic | GP3 in GS7 Vs GP3 in GS6 | p<0.01 | Tissue | 30611450 |